Suppr超能文献

心力衰竭患者炎症与无事件生存之间关联的性别差异。

Sex Differences in the Association Between Inflammation and Event-Free Survival in Patients With Heart Failure.

出版信息

J Cardiovasc Nurs. 2022;37(4):386-393. doi: 10.1097/JCN.0000000000000831. Epub 2021 Jul 8.

Abstract

BACKGROUND

Heart failure (HF) is associated with chronic inflammation, which is adversely associated with survival. Although sex-related differences in inflammation have been described in patients with HF, whether sex-related differences in inflammation are associated with event-free survival has not been examined.

AIM

The aim of this study was to determine whether the association between inflammation as indicated by tumor necrosis factor-α and event-free survival differs between men and women with HF after controlling for demographic and clinical variables.

METHOD

This was a secondary analysis of data from 301 male (age, 61.0 ± 11.4 years) and 137 female (age, 60.3 ± 12.1 years) patients with HF. Serum levels of soluble tumor necrosis factor receptor 1 were used to indicate inflammatory status. Patients were grouped according to median split of soluble tumor necrosis factor receptor 1 level and sex into male with low inflammation (≤1820 pg/mL) (n = 158) or high inflammation (>1820 pg/mL) (n = 143), and female with low inflammation (n = 63) or high inflammation (n = 74). Cox regression models were run separately for men and women to determine whether inflammation contributed to differences in event-free survival between sexes with HF.

RESULTS

There were 84 male (27.9%) and 27 female (19.7%) patients who had an event. Event-free survival in women did not differ by the severity of inflammation in the Cox regression analysis. In contrast, men with high inflammation had 1.85 times higher risk for an event compared with men with low inflammation.

CONCLUSION

These data provide evidence that inflammation contributed to differences in event-free survival in men but not women with HF. Clinicians should be aware that men who have higher inflammation may be at a greater risk of HF or cardiac-related events than others with HF.

摘要

背景

心力衰竭(HF)与慢性炎症有关,而慢性炎症与生存率呈负相关。尽管已有研究描述了 HF 患者中性别相关的炎症差异,但炎症的性别差异是否与无事件生存率相关尚未得到检验。

目的

本研究旨在确定在控制人口统计学和临床变量后,HF 患者中肿瘤坏死因子-α(TNF-α)所示炎症与无事件生存率之间的关联是否因性别而异。

方法

这是对 301 名男性(年龄 61.0 ± 11.4 岁)和 137 名女性(年龄 60.3 ± 12.1 岁)HF 患者数据的二次分析。血清可溶性肿瘤坏死因子受体 1(sTNF-R1)水平用于指示炎症状态。根据 sTNF-R1 水平和性别中位数分为男性低炎症组(≤1820 pg/mL,n = 158)或高炎症组(>1820 pg/mL,n = 143)和女性低炎症组(n = 63)或高炎症组(n = 74)。分别为男性和女性运行 Cox 回归模型,以确定炎症是否导致 HF 患者性别之间的无事件生存率存在差异。

结果

84 名男性(27.9%)和 27 名女性(19.7%)患者发生了事件。在 Cox 回归分析中,女性炎症严重程度与无事件生存率无关。相比之下,高炎症男性发生事件的风险是低炎症男性的 1.85 倍。

结论

这些数据提供了证据表明,炎症导致 HF 男性而非女性的无事件生存率存在差异。临床医生应该意识到,与其他 HF 患者相比,炎症水平较高的男性可能面临更大的 HF 或心脏相关事件风险。

相似文献

1
Sex Differences in the Association Between Inflammation and Event-Free Survival in Patients With Heart Failure.
J Cardiovasc Nurs. 2022;37(4):386-393. doi: 10.1097/JCN.0000000000000831. Epub 2021 Jul 8.
2
Symptom clusters in men and women with heart failure and their impact on cardiac event-free survival.
J Cardiovasc Nurs. 2010 Jul-Aug;25(4):263-72. doi: 10.1097/JCN.0b013e3181cfbb88.
3
The health outcomes of inflammation and obesity in patients with heart failure.
Heart Lung. 2020 Nov-Dec;49(6):896-901. doi: 10.1016/j.hrtlng.2020.05.010. Epub 2020 Jun 5.
6
The link of unintentional weight loss to cardiac event-free survival in patients with heart failure.
J Cardiovasc Nurs. 2014 Sep-Oct;29(5):439-47. doi: 10.1097/JCN.0b013e3182a46ba8.
8
Health-Related Quality of Life, Functional Status, and Cardiac Event-Free Survival in Patients With Heart Failure.
J Cardiovasc Nurs. 2016 May-Jun;31(3):236-44. doi: 10.1097/JCN.0000000000000248.
9
Age-related sex differences in the outcomes of patients with hypertrophic cardiomyopathy.
PLoS One. 2022 Feb 25;17(2):e0264580. doi: 10.1371/journal.pone.0264580. eCollection 2022.
10

本文引用的文献

1
The health outcomes of inflammation and obesity in patients with heart failure.
Heart Lung. 2020 Nov-Dec;49(6):896-901. doi: 10.1016/j.hrtlng.2020.05.010. Epub 2020 Jun 5.
3
High Dietary Sodium Intake is Associated with Shorter Event-Free Survival in Patients with Heart Failure and Comorbid Diabetes.
Clin Nurs Res. 2021 Feb;30(2):154-160. doi: 10.1177/1054773819888743. Epub 2019 Nov 18.
4
Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.
J Am Heart Assoc. 2019 Oct 15;8(20):e013441. doi: 10.1161/JAHA.119.013441. Epub 2019 Oct 5.
5
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.
Circulation. 2019 Mar 5;139(10):e56-e528. doi: 10.1161/CIR.0000000000000659.
6
Therapeutic Approaches Targeting Inflammation in Cardiovascular Disorders.
Biology (Basel). 2018 Nov 16;7(4):49. doi: 10.3390/biology7040049.
7
Micronutrient Deficiency Independently Predicts Time to Event in Patients With Heart Failure.
J Am Heart Assoc. 2018 Sep 4;7(17):e007251. doi: 10.1161/JAHA.117.007251.
8
Tumor Necrosis Factor-α in Heart Failure: an Updated Review.
Curr Cardiol Rep. 2018 Sep 26;20(11):117. doi: 10.1007/s11886-018-1067-7.
9
Cardiomyopathies and Related Changes in Contractility of Human Heart Muscle.
Int J Mol Sci. 2018 Jul 31;19(8):2234. doi: 10.3390/ijms19082234.
10
Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines.
Front Immunol. 2018 Apr 9;9:586. doi: 10.3389/fimmu.2018.00586. eCollection 2018.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验